Literature DB >> 29421293

Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease.

Sayan Basu1, Swapna S Shanbhag2, Arjun Gokani3, Richa Kedar2, Chirag Bahuguna3, Virender S Sangwan4.   

Abstract

PURPOSE: To describe the long-term ocular and visual morbidity in children with chronic sequelae of Stevens-Johnson syndrome (SJS) and visual outcomes of various management strategies.
DESIGN: Retrospective comparative case series.
METHODS: This study included 568 eyes of 284 children with SJS who presented between 1990 and 2015. Affected eyes received either conservative therapy (n = 440) or definitive management (n = 128), including lid margin mucous membrane grafting (MMG), prosthetic replacement of the ocular surface ecosystem (PROSE) contact lenses, allogeneic limbal transplantation, or keratoprosthesis using an algorithmic approach based on the severity of dryness and cause and extent of corneal damage. The primary outcome measure was best-corrected visual acuity (BCVA).
RESULTS: Two thirds of patients presented more than a year after acute SJS, 99% without prior amniotic membrane grafting, with low vision or blindness in 60% of eyes. Children 8 years or younger in age had significantly worse ocular and visual morbidity (P ≤ .037). At 5 years of follow-up, definitive therapy significantly altered the natural history of the disease by improving BCVA and preventing the development or progression of keratopathy, as compared to conservative therapy (P ≤ .002). In eyes with lid-related keratopathy, MMG was significantly more effective than PROSE, although both were significantly better than conservative therapy and the combination of MMG followed by PROSE provided the best results (P < .0001).
CONCLUSION: Children receiving suboptimal care during acute SJS presented later with severe ocular and visual morbidity. Timely therapy, particularly with PROSE and MMG in eyes with lid-related keratopathy, changed the natural course and helped in preserving and improving vision.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29421293     DOI: 10.1016/j.ajo.2018.01.028

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Authors:  Swapna S Shanbhag; Ramy Rashad; James Chodosh; Hajirah N Saeed
Journal:  Am J Ophthalmol       Date:  2019-07-19       Impact factor: 5.258

Review 2.  Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Authors:  Michele L Ramien; Danny Mansour; Neil H Shear
Journal:  Paediatr Drugs       Date:  2022-06-09       Impact factor: 3.022

3.  Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; Leangelo Hall; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-03-19       Impact factor: 5.033

4.  Prosthetic Replacement of the Ocular Surface Ecosystem Treatment for Ocular Surface Disease in Pediatric Patients With Stevens-Johnson Syndrome.

Authors:  Yvonne Wang; Rohini Rao; Deborah S Jacobs; Hajirah N Saeed
Journal:  Am J Ophthalmol       Date:  2019-01-19       Impact factor: 5.258

5.  Clinical Characteristics of Patients With Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom.

Authors:  Samir Jabbour; Nizar Din; Abison Logeswaran; Sara Taberno Sanchez; Sajjad Ahmad
Journal:  Front Med (Lausanne)       Date:  2021-05-24

6.  Diphtheroids as Corneal Pathogens in Chronic Ocular Surface Disease in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Authors:  Swapna S Shanbhag; Grace Shih; Paulo J M Bispo; James Chodosh; Deborah S Jacobs; Hajirah N Saeed
Journal:  Cornea       Date:  2021-06-01       Impact factor: 3.152

Review 7.  An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic.

Authors:  Pragnya R Donthineni; Swapna S Shanbhag; Sayan Basu
Journal:  Healthcare (Basel)       Date:  2021-01-17

Review 8.  Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention.

Authors:  Swapna S Shanbhag; Madhuri A Koduri; Chitra Kannabiran; Pragnya R Donthineni; Vivek Singh; Sayan Basu
Journal:  Front Genet       Date:  2021-01-12       Impact factor: 4.599

9.  Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients.

Authors:  Matias Soifer; Hazem M Mousa; Robert B Levy; Victor L Perez
Journal:  Front Med (Lausanne)       Date:  2021-05-21

10.  Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.

Authors:  Yamato Yoshikawa; Mayumi Ueta; Hiromi Nishigaki; Shigeru Kinoshita; Tsunehiko Ikeda; Chie Sotozono
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.